Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00500084
Status:
TERMINATED
Last Update Posted:
2014-10-24
First Post:
2007-07-10
Brief Title:
Phase III ALTU-135 CP Safety Trial
Sponsor:
Anthera Pharmaceuticals
Organization:
Anthera Pharmaceuticals